Andreea Mocofan previously worked in the pharmaceutical sector for companies like Pfizer and MSD. Mocofan returned to Romania after being a Board member of a professional association in Norway’s pharmaceutical industry, according to LinkedIn.

“I am honored to join the team of Johnson&Johnson Romania and contribute to building a world in which complex diseases are prevented, treated and cured. Together we can have a huge impact on Romanian patients’ health. The commitment toward patients, medical community, partners and colleagues represents a significant source of inspiration and energy for me and my team,” said Andreea Mocofan, Country Director Johnson&Johnson Innovative Medicine Romania.

Johnson&Johnson ranks fifth in the Romanian pharmaceutical market, by value, with sales of RON1.2 billion in 2024, as per a report by market research company Cegedim.